Stroke:卒中后运动恢复情况怎么预测?锥体外系支招

2018-10-28 国际循环编辑部 国际循环

纤维束弥散张量成像增加williamhill asia 对于卒中后不同通路损伤对残余运动功能影响的认识。例如,皮质脊髓束(CST)的完整性有助于了解和预测卒中过程。但目前有关判断基底神经节之间的锥体外系对卒中后运动功能影响的数据较少。Stroke发表的一项最新研究探讨锥体外系完整性与卒中后精细运动功能表现的相关性。

纤维束弥散张量成像增加williamhill asia 对于卒中后不同通路损伤对残余运动功能影响的认识。例如,皮质脊髓束(CST)的完整性有助于了解和预测卒中过程。但目前有关判断基底神经节之间的锥体外系对卒中后运动功能影响的数据较少。Stroke发表的一项最新研究探讨锥体外系完整性与卒中后精细运动功能表现的相关性。

该研究共计入选26例健康志愿者,行纤维束追踪成像,重建连接黑质与苍白球的黑质-苍白球通路及CST。此外,研究入选20例患者于卒中3个月后评估上述通路及CST并采用各项异性分数评估纤维结构的完整性,于卒中后1年分别采用握力及九孔柱试验分别评估患者的粗细运动能力。此外,为评估影响九孔柱试验的因素,研究还采用多变量模型进行分析。

所有受试者的黑质-苍白球通路均可追踪到,且与CST无重叠,并通过丘脑底核。在卒中患者中,病变同侧的黑质-苍白球通路的各向异性分数显著降低(比率:0.96±0.02,P=0.021);卒中1年后所累及的手行九孔柱试验所需时间明显更长但双手握力相似。进一步分析发现,黑质-苍白球通路的完整性降低、CST完整性降低及年龄较小均与九孔柱试验所示的运动能力较差具有相关性(P分别为0.040、<0.001和<0.001)。

总之,包含连接下丘脑底核的黑质-苍白球通路是锥体外系中非常重要的部分,可在目前已知CST之外影响卒中后的残余精细运动功能,可为预测卒中后运动恢复情况提供支持性信息。

原始出处:
D.Leander Rimmele, Benedikt M.Frey, Bastian Cheng, et al. Association of Extrapyramidal Tracts’ Integrity With Performance in Fine Motor Skills After Stroke. Stroke. Oct 17. 

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1815082, encodeId=7e0b1815082d6, content=<a href='/topic/show?id=321596e49d3' target=_blank style='color:#2F92EE;'>#锥体外系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96749, encryptionId=321596e49d3, topicName=锥体外系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Oct 30 01:32:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774967, encodeId=48581e749675f, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Fri Apr 26 11:32:00 CST 2019, time=2019-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671353, encodeId=1eb816e13538b, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026193, encodeId=3c7d1026193cb, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Oct 28 14:32:00 CST 2018, time=2018-10-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1815082, encodeId=7e0b1815082d6, content=<a href='/topic/show?id=321596e49d3' target=_blank style='color:#2F92EE;'>#锥体外系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96749, encryptionId=321596e49d3, topicName=锥体外系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Oct 30 01:32:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774967, encodeId=48581e749675f, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Fri Apr 26 11:32:00 CST 2019, time=2019-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671353, encodeId=1eb816e13538b, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026193, encodeId=3c7d1026193cb, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Oct 28 14:32:00 CST 2018, time=2018-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1815082, encodeId=7e0b1815082d6, content=<a href='/topic/show?id=321596e49d3' target=_blank style='color:#2F92EE;'>#锥体外系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96749, encryptionId=321596e49d3, topicName=锥体外系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Oct 30 01:32:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774967, encodeId=48581e749675f, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Fri Apr 26 11:32:00 CST 2019, time=2019-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671353, encodeId=1eb816e13538b, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026193, encodeId=3c7d1026193cb, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Oct 28 14:32:00 CST 2018, time=2018-10-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1815082, encodeId=7e0b1815082d6, content=<a href='/topic/show?id=321596e49d3' target=_blank style='color:#2F92EE;'>#锥体外系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96749, encryptionId=321596e49d3, topicName=锥体外系)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Tue Oct 30 01:32:00 CST 2018, time=2018-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774967, encodeId=48581e749675f, content=<a href='/topic/show?id=17135e073b5' target=_blank style='color:#2F92EE;'>#支招#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57073, encryptionId=17135e073b5, topicName=支招)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c21738724507, createdName=psybestwish, createdTime=Fri Apr 26 11:32:00 CST 2019, time=2019-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671353, encodeId=1eb816e13538b, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Nov 17 10:32:00 CST 2018, time=2018-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026193, encodeId=3c7d1026193cb, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Sun Oct 28 14:32:00 CST 2018, time=2018-10-28, status=1, ipAttribution=)]
    2018-10-28 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关威廉亚洲官网

JAMA Neurol:右旋安非他明联合理疗不能改善脑卒中患者的运动功能

研究认为,右旋安非他明联合理疗不能改善脑卒中患者的运动功能

Stroke:急性脑卒中后血压波动越大 结局越糟糕!

2018年7月,发表于《Stroke》上的一项研究,表明了脑出血后血压变异性(BPV)的增加会加剧更差的结局。

J Neurol Neurosur Ps:他汀类药物与脑卒中患者脑出血风险的关系

由此可见,无论卒中亚型如何,他汀类药物治疗对未来ICH均无明显趋势。然而,这种风险因他汀类药物使用者死亡率和功能结局的显著改善而被掩盖。

天津建成9家**脑卒中中心

卒中中心建设是天津市2018年20项民心工程之一。该工程提出,力争到今年年底建成8家国家级脑卒中中心,将患者到达医院至开始静脉溶栓治疗的平均时间缩短至60分钟内。截至目前,天津市已建成9家国家级脑卒中中心,该项民心工程建设任务已经提前超额完成。

Stroke:轻型脑卒中 哪些情况需开始静脉溶栓治疗?

2018年7月,发表于《Stroke》上的一项研究,考察了静脉溶栓治疗轻型脑卒中的影响因素。

CNS Drugs:SSRIs在改善脑卒中后功能结局上有何作用?

2018年10月,发表于《CNS Drugs》上的一项研究,考察了选择性5-羟色胺再摄取抑制剂(SSRIs)改善脑卒中后功能结局方面的潜在作用。